C. Lemaire

发表

Treating diabetes with islet transplantation: lessons from the past decade in Lille.

F. Pattou, E. Thervet, R. Caiazzo, 2014, Diabetes & metabolism.

Partial kilovoltage cone beam computed tomography, complete kilovoltage cone beam computed tomography, and electronic portal images for breast radiation therapy: A dose-comparison study.

M. Yassa, H. Bahig, P. Vavassis, 2015, Practical radiation oncology.

Higher carbohydrate intake is associated with decreased incidence of newborn macrosomia in women with gestational diabetes.

A. Vambergue, R. Beuscart, M. Romon, 2001, Journal of the American Dietetic Association.

High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: Results of a phase III randomized study.

J. Bahary, N. Carrier, L. Souhami, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of Life in Patients with Testosterone Recovery after Long Term Androgen Deprivation Therapy for High Risk Prostate Cancer

J. Bahary, N. Carrier, L. Souhami, 2014 .

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Do-Hoon Kim, R. Vandermeer, T. Whelan, 2019, The Lancet.

Causes of death in intermediate- and high-risk prostate cancer treated with radiotherapy with or without androgen deprivation therapy: Analysis from two phase III trials.

É. Vigneault, J. Bahary, N. Carrier, 2016 .

Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.

J. Bahary, N. Carrier, L. Souhami, 2013 .

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.

J. Bahary, N. Carrier, L. Souhami, 2018, European urology.

Long-term quality of life in high-risk prostate cancer: Results of a phase III randomized trial.

J. Bahary, N. Carrier, L. Souhami, 2014 .

Duration of androgen deprivation therapy in high risk prostate cancer: Final results of a randomized phase III trial.

J. Bahary, N. Carrier, L. Souhami, 2017 .

[Primary ovarian carcinoid with secretion of human pancreatic polypeptide and immunoreactivity to substance P].

J. Chayvialle, C. Proye, J. Lefebvre, 1988, Chirurgie; memoires de l'Academie de chirurgie.

PO-0668 TESTOSTERONE VARIATION IN INTERMEDIATE RISK PROSTATE CANCER TREATED WITH ANDROGEN BLOCKADE AND RADIOTHERAPY

É. Vigneault, N. Carrier, L. Souhami, 2012 .